Cytokines in heart failure

Area of Science:

• Cardiology
• Immunology
• Biochemistry

Background:

• Heart failure (HF) progression involves structural and functional changes preceding clinical symptoms.
• Numerous cytokines from cardiac and non-cardiac tissues are implicated in HF.
• Circulating cytokine levels correlate with HF development and severity.

Purpose of the Study:

• To discuss the pathophysiological roles of cytokines in HF.
• To explore the utility of cytokines as predictive biomarkers for HF.
• To highlight the need for understanding cytokine networks in distinct HF phenotypes for new therapies.

Main Methods:

• Review of intracardiac and extracardiac cytokine origins in HF.
• Analysis of cytokine modulation of inflammation, myocyte stress, injury, apoptosis, fibroblast activation, and extracellular matrix remodeling.
• Discussion of clinical considerations for cytokine use as prognostic biomarkers and therapeutic targets.

Main Results:

• Cytokines are key mediators in HF pathogenesis, influencing inflammation and cardiac remodeling.
• Cytokine levels serve as important predictive biomarkers for HF progression and severity.
• Distinct cytokine networks contribute to different HF phenotypes, such as HF with reduced or preserved ejection fraction.

Conclusions:

• A comprehensive understanding of the cytokine network is essential for advancing HF treatment strategies.
• Cytokines hold significant potential as both prognostic biomarkers and therapeutic targets in managing heart failure.
• Further research into cytokine-mediated mechanisms is crucial for personalized HF management.